S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
S&P 500   3,852.36
DOW   32,920.46
QQQ   300.92
15 Ways to Improve Your Credit
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
These 2 Healthcare Stocks Have Doubled in 2023
Bed Bath & Beyond Is Circling the Drain
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Pfizer Stock: What the Bulls and Bears are Getting Wrong
Allegro Microsystems Is A Well-Positioned Semiconductor Stock
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
AMD Results Are No Reason To Buy Semiconductors... Yet
Institutions are Buying up Procter & Gamble Shares, Should you?
NASDAQ:TIL

Instil Bio - TIL Stock Forecast, Price & News

$0.87
+0.05 (+6.12%)
(As of 02/1/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.81
$0.89
50-Day Range
$0.48
$1.48
52-Week Range
$0.47
$13.01
Volume
1.51 million shs
Average Volume
1.38 million shs
Market Capitalization
$112.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.33

Instil Bio MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
399.8% Upside
$4.33 Price Target
Short Interest
Healthy
4.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.32mentions of Instil Bio in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.68) to ($1.11) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

137th out of 1,053 stocks

Biological Products, Except Diagnostic Industry

25th out of 170 stocks


TIL stock logo

About Instil Bio (NASDAQ:TIL) Stock

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Receive TIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Instil Bio and its competitors with MarketBeat's FREE daily newsletter.

TIL Stock News Headlines

TIL Instil Bio, Inc.
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
What 4 Analyst Ratings Have To Say About Instil Bio
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Instil Bio drops 11% as clinical priorities change
What 6 Analyst Ratings Have To Say About Instil Bio
See More Headlines
Receive TIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Instil Bio and its competitors with MarketBeat's FREE daily newsletter.

TIL Company Calendar

Last Earnings
11/14/2022
Today
2/02/2023
Next Earnings (Estimated)
3/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TIL
Fax
N/A
Employees
412
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.33
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+399.8%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-156,790,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$140,000.00
Book Value
$4.31 per share

Miscellaneous

Free Float
62,902,000
Market Cap
$112.44 million
Optionable
Not Optionable
Beta
1.34

Key Executives

  • Mr. Bronson CrouchMr. Bronson Crouch (Age 50)
    Chairman & CEO
    Comp: $998.42k
  • Dr. Sandeep Laumas M.D.Dr. Sandeep Laumas M.D. (Age 54)
    CFO & Chief Bus. Officer
  • Dr. Mark E. Dudley Ph.D.
    Chief Scientific Officer
  • Ms. Sumita Ray J.D. (Age 49)
    Chief Legal, Compliance, & Admin. Officer
  • Dr. Robert Hawkins MBBS
    Ph.D., Head of R&D













TIL Stock - Frequently Asked Questions

Should I buy or sell Instil Bio stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Instil Bio in the last year. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TIL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TIL, but not buy additional shares or sell existing shares.
View TIL analyst ratings
or view top-rated stocks.

What is Instil Bio's stock price forecast for 2023?

5 Wall Street research analysts have issued 12 month price objectives for Instil Bio's shares. Their TIL share price forecasts range from $2.00 to $6.00. On average, they anticipate the company's stock price to reach $4.33 in the next year. This suggests a possible upside of 399.8% from the stock's current price.
View analysts price targets for TIL
or view top-rated stocks among Wall Street analysts.

How have TIL shares performed in 2023?

Instil Bio's stock was trading at $0.63 at the start of the year. Since then, TIL stock has increased by 37.6% and is now trading at $0.8670.
View the best growth stocks for 2023 here
.

Are investors shorting Instil Bio?

Instil Bio saw a decrease in short interest in January. As of January 15th, there was short interest totaling 3,020,000 shares, a decrease of 20.1% from the December 31st total of 3,780,000 shares. Based on an average daily volume of 1,550,000 shares, the days-to-cover ratio is presently 1.9 days. Approximately 4.5% of the shares of the company are short sold.
View Instil Bio's Short Interest
.

When is Instil Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 6th 2023.
View our TIL earnings forecast
.

How were Instil Bio's earnings last quarter?

Instil Bio, Inc. (NASDAQ:TIL) announced its quarterly earnings results on Monday, November, 14th. The company reported ($0.43) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.44) by $0.01.

What other stocks do shareholders of Instil Bio own?
When did Instil Bio IPO?

(TIL) raised $250 million in an initial public offering (IPO) on Friday, March 19th 2021. The company issued 13,900,000 shares at a price of $17.00-$19.00 per share. Morgan Stanley, Jefferies, Cowen and Truist Securities served as the underwriters for the IPO.

What is Instil Bio's stock symbol?

Instil Bio trades on the NASDAQ under the ticker symbol "TIL."

Who are Instil Bio's major shareholders?

Instil Bio's stock is owned by many different retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include R Kent Mcgaughy Jr and Vivo Capital Ix, Llc.
View institutional ownership trends
.

How do I buy shares of Instil Bio?

Shares of TIL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Instil Bio's stock price today?

One share of TIL stock can currently be purchased for approximately $0.87.

How much money does Instil Bio make?

Instil Bio (NASDAQ:TIL) has a market capitalization of $112.44 million and generates $140,000.00 in revenue each year. The company earns $-156,790,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis.

How many employees does Instil Bio have?

The company employs 412 workers across the globe.

How can I contact Instil Bio?

Instil Bio's mailing address is CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z. The official website for the company is www.tillcap.com. The company can be reached via phone at 972-499-3350 or via email at info@tillcap.com.

This page (NASDAQ:TIL) was last updated on 2/2/2023 by MarketBeat.com Staff